* Bio Path Holdings Inc BPTH.OQ reported a quarterly
adjusted
loss of 53 cents per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 52 cents
per share.
* Reported revenue was zero; analysts expected zero.
* Bio Path Holdings Inc's reported EPS for the quarter was a
loss
of 53 cents.
* The mean earnings estimate of analysts had fallen by
about 18.2%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* Bio Path Holdings Inc shares had fallen by 75.9% this
quarter and lost 71.6% so far this year.
* The company reported a quarterly loss of $4.23 million.
* Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $12.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 15 at 01:31 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.52 -0.53 Missed
Mar. 31 2023 -0.45 -0.66 Missed
Dec. 31 2022 -0.45 -0.52 Missed
Sep. 30 2022 -0.45 -0.49 Missed